Med. praxi. 2017;14(1):16-20 | DOI: 10.36290/med.2017.004

Some aspects of diagnostics and treatment of cough especially in pregnancy and children

MUDr. Michal Švarc
Plicní klinika, FN Hradec Králové

Cough is a common symptom of many diseases. Cough could be according to it’s duration acute, subacute or chronic. Differential

diagnostics may vary. The therapy is either specific according to the underlying disease or symptomatic including anti tussive,

mucolytic or expectorant drugs. The therapy of pregnant patients or children must be guided according to the restricitions and

limitations of drugs intended for treatment of those two special groups. Eligible antibiotics for pregnant patients are penicilin

derived, selected macrolides and clindamycin. Most of the asthma controling drugs are approved for treatment of asthma in

pregnancy. An unadvised therapy termination is linked to higher risk of exacerbation of asthma. Symptomatic treatment lies with

the use of antitussive drugs such as dextromethorfan or butamirate for treatment of non productive cough. Productive cough

can be treated with ambroxol, erdostein and N-acetylcesteine.

Keywords: cough, pregnancy, children, asthma, antitussive drugs, mucolytic drugs, expectorant drugs, N-acetylcysteine

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Švarc M. Some aspects of diagnostics and treatment of cough especially in pregnancy and children. Med. praxi. 2017;14(1):16-20. doi: 10.36290/med.2017.004.
Download citation

References

  1. Amin AF. N-acetylcysteine for treatment of recurrent unexplained pregnancy loss. Reproductive BioMedicine 2008; 17(5): 722-726. Go to original source...
  2. Blasi F. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections. Respiratory Medicine 2016; 117: 190-197. Go to original source...
  3. Boler DC. Cough Suppressant and Pharmacologic Protussive Therapy: ACCP Evidence-Based Clinical Practice Guidelines. Chest 2006; 129(Suppl. 1): 238S-249S. Go to original source... Go to PubMed...
  4. Braman SS. Postinfectious Cough: ACCP Evidence-Based Clinical Practice Guidelines, Chest. 2006; 129(Suppl. 1): 138S-146S. Go to original source... Go to PubMed...
  5. Čáp P. Akutní a chronický kašel teorie a praxe. Mladá fronta 2013: 160 s.
  6. Dal Negro RW. Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study. European Respiratory Journal 2015; 46: PA1495. Go to original source...
  7. De Blasio F. Cough management: a practical approach, Cough 2011; 7(7). Go to original source... Go to PubMed...
  8. Elahi M, Elahi H. The Effects of N-Acetyl Cysteine on Nasal Mucociliary Clearance in Healthy Volunteers: A Randomized, Double-Blind and Placebo-Controlled Study. Otolaryngology 2015; 5: 182.
  9. Fajt M. Dušení při postižení v oblasti horních dýchacích cest u dětí. Pediatr. pro Praxi, 2004: 1.
  10. Hadašová A, Pozler O. Gastroezofageální reflux u dětí. Postgraduální medicína 2003: 6.
  11. Juřica J. Moderní terapie kašle. Pediatr. praxi 2013; 14(1): 30-38.
  12. Kopřiva F. Dvě tváře guaifenesinu v léčbě kašle. Remedia 2013: 1.
  13. Kudělová J. Volba farmakoterapie u těhotných v ordinaci plicního lékaře. Remedia 2014: 3.
  14. Li Yu. Advances in upper airway cough syndrome. Kaohsiung Journal of Medical Sciences 2015; 31: 223-228. Go to original source... Go to PubMed...
  15. Novák I. Léčba akutní subglotické laryngitidy. Pediatr. pro Praxi 2007; 8(6): 401-402.
  16. Pratter MR. An Empiric Integrative Approach to the Management of Cough : ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2006; 129(Suppl. 1): 222S-231S. Go to original source... Go to PubMed...
  17. Rokyta R, Hutyra M, Jansa P. Doporučené postupy Evropské kardiologické společnosti pro diagnostiku a léčbu akutní plicní embolie, verze 2014, 10.1016/j.crvasa.2015.05.00
  18. Rochat T. N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells, J Cell Physiol. 2004; 201(1): 106-116. Go to original source... Go to PubMed...
  19. Růžičková-Kirchnerová O. Diagnostika a léčba plicních nemocí v těhotenství. GEUM; 2013: 183 s.
  20. Sanguinetti CM. N-acetylcysteine in COPD: why, how, and when? Multidisciplinary Respiratory Medicine 2016; 11(8). Go to original source...
  21. Vančíková Z. Kašel u dětí - teorie a praxe. Postgraduální medicína 2015: 3.
  22. Vospělová J, Kolek A. Gastroezofageální reflux a nemoc z ger u dětí z pohledu medicíny založené na důkazech. Pediatrie pro praxi 2003: 3.
  23. www.drugs.com, 2. 2. 2017
  24. www.sukl.cz, 2. 2. 2017




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.